RxAnte: Funding, Investors & Team (Sep 2026)
RxAnte is a leading predictive analytics and clinical services company dedicated to improving medication use and health outcomes. By providing health plans and providers with actionable insights, strategies, and a portfolio of interventions, RxAnte helps make medications work better for everyone. Created by experts in advanced analytics, medication adherence, health IT, and quality improvement, the RxAnte portfolio of solutions includes patented platforms that leverage predictive and decision analytics, advanced program evaluation methods, a web-based work flow solution, and an award-winning call center to provide clients with the insights they need and results they want in improving medication use.
RxAnte has raised $15.0M across 2 funding rounds on record, the most recent an undisclosed round announced in Jan 2026.
RxAnte Company Profile and Key Stats
Latest funding round on record: Jan 2026.
RxAnte Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
RxAnte raised $15.0M in an undisclosed round announced in Dec 2022.
3.1 years later, an undisclosed round was announced in Jan 2026 with no disclosed amount.
RxAnte Founders and Leadership Team
Contact details for the RxAnte team: 1 of 2 have an email address on file.
Start 14-day free trial →RxAnte Funding Compared to Other Artificial Intelligence Startups
Funded Startups Like RxAnte in Artificial Intelligence and Portland
Companies Similar to RxAnte
Cradlewise is an intelligent baby crib that learns from the baby's sleep patterns, spots the first signs of…
Capacity is an AI-powered helpdesk that automates support for customers and employees. Capacity connects…
AfterQuery is an artificial intelligence research and data platform focused on creating high-quality,…
The future of translation is conversational and Language I/O’s proprietary machine translation optimization…
Greptile is a platform driven by artificial intelligence that evaluates codebases and improves development…
Rhealth is a biotechnology company offering hospitals health management solutions utilizing advanced AI…
Socure is a predictive analytics platform for digital identity verification of consumers. Socure's predictive…
Instinct is an artificial intelligence startup developing AI technology.
Significant gives vehicle-mounted PC vision innovation that distinguishes visual deformities in network…
Cloverleaf AI exists to help you fill your pipeline with high-quality SLED leads. Tell us what you deliver,…
Emerald AI develops software and platforms that manage and coordinate energy use for artificial intelligence…
RxAnte Funding FAQs
What does RxAnte do?
RxAnte is a leading predictive analytics and clinical services company dedicated to improving medication use and health outcomes. By providing health plans and providers with actionable insights, strategies, and a portfolio of interventions, RxAnte helps make medications work better for everyone. Created by experts in advanced analytics, medication adherence, health IT, and quality improvement, the RxAnte portfolio of solutions includes patented platforms that leverage predictive and decision analytics, advanced program evaluation methods, a web-based work flow solution, and an award-winning call center to provide clients with the insights they need and results they want in improving medication use.
How much funding has RxAnte raised?
RxAnte has raised $15.0M across 2 rounds on record.
When did RxAnte last raise funding?
RxAnte's most recent funding round on record was announced in Jan 2026. The amount was not disclosed.
Who founded RxAnte?
FundedIQ lists Joshua S Benner (Founder) at RxAnte.
Who is the CEO of RxAnte?
Josh Benner is listed as CEO at RxAnte.
Where is RxAnte headquartered?
RxAnte is based in Portland, Maine, United States.
How many employees does RxAnte have?
RxAnte is in the 101-250 employee band.
About FundedIQ's RxAnte Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for RxAnte is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.